Early detection of HPV-associated oropharyngeal cancer-Authors' reply

Affiliations

¹ Christie NHS Foundation Trust, Manchester, UK.
² School of Nursing and Midwifery, Queen's University Belfast, Belfast BT9 7AE, UK; Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast BT9 7AE, UK.
³ HPV Action, London, UK.
⁴ Royal Marsden Hospital, London, UK.
⁵ Weston Integrated Sexual Health Centre, Weston-super-Mare, UK.
⁶ Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast BT9 7AE, UK; European Cancer Organisation Oncopolicy Forum, Brussels, Belgium. Electronic address: mark.lawler@qub.ac.uk.

Comment

Donna Graham et al. Lancet. 2019.

. 2019 May 25;393(10186):2123-2124.

doi: 10.1016/S0140-6736(19)30291-0.

¹ Christie NHS Foundation Trust, Manchester, UK.
² School of Nursing and Midwifery, Queen's University Belfast, Belfast BT9 7AE, UK; Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast BT9 7AE, UK.
³ HPV Action, London, UK.
⁴ Royal Marsden Hospital, London, UK.
⁵ Weston Integrated Sexual Health Centre, Weston-super-Mare, UK.
⁶ Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast BT9 7AE, UK; European Cancer Organisation Oncopolicy Forum, Brussels, Belgium. Electronic address: mark.lawler@qub.ac.uk.

No abstract available

Comment on

Early detection of HPV-associated oropharyngeal cancer.
Lechner M, Breeze CE, O'Mahony JF, Masterson L. Lechner M, et al. Lancet. 2019 May 25;393(10186):2123. doi: 10.1016/S0140-6736(19)30227-2. Lancet. 2019. PMID: 31226048 No abstract available.